Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Diabetes Care · 2002 · 10.4K citations

Medicine, Endocrinology, Internal Medicine +11

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Diabetes Care · 1997 · 6.2K citations

Medicine, Endocrinology, Internal Medicine +11

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.

Allard C. van der Wal, A E Becker, Chris M. van der Loos et al. · Circulation · 1994 · 1.9K citations · Full text

Medicine, Cardiology, Pathology +17

Cerebrovascular disease in the community: results of a WHO collaborative study.

Kari Aho, Per Harmsen, J Marquardsen et al. · PubMed · 1980 · 1.3K citations

Medicine, Community Health, Preventive Medicine +16

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction

Rainer H. Böger, Stefanie M. Bode‐Böger, Andrzej Szuba et al. · Circulation · 1998 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacology +12